HPV Vaccine Uptake, Willingness to Receive, and Causes of Vaccine Hesitancy: A National Study Conducted in Saudi Arabia Among Female Healthcare Professionals
Nouf AlShamlan,Reem AlOmar,Assim AlAbdulKader,Marwa Shafey,Faisal AlGhamdi,Abdullah Aldakheel,Saud AlShehri,Lyana Felemban,Shahad AlShamlan,Malak Al Shammari
DOI: https://doi.org/10.2147/ijwh.s449979
2024-03-14
International Journal of Women s Health
Abstract:Nouf A AlShamlan, 1 Reem S AlOmar, 1 Assim M AlAbdulKader, 1 Marwa Mahmoud Shafey, 1 Faisal A AlGhamdi, 2 Abdullah A Aldakheel, 2 Saud A AlShehri, 2 Lyana A Felemban, 3 Shahad A AlShamlan, 2 Malak A Al Shammari 1 1 Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2 College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 3 College of Medicine, Fakeeh College of Medical Sciences, Jeddah, Saudi Arabia Correspondence: Nouf A AlShamlan, Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia, Tel +966504901406, Email Background: Epidemiological evidence has shown that human papillomavirus (HPV) is the most frequent cause of sexually transmitted infection, and vaccination is an essential measure to prevent associated diseases and complications. This study aimed to assess the HPV vaccine uptake and its associated factors as well as HPV vaccine hesitancy by female healthcare workers (HCWs) in Saudi Arabia. Methods: This online, questionnaire-based, cross-sectional study involved female HCWs in Saudi Arabia between July and October 2022. The study tool included questions about sociodemographic, occupational, and reproductive characteristics, uptake of HPV vaccination, and reasons of hesitancy. Chi-squared and t-tests were used for bivariate analyses, and multivariable logistic regression was used to adjust for confounders. Results: The total number of participants was 1857. Around 20% of HCWs received at least one dose of the HPV vaccine, and around 45% were willing to take it this year. Lower odds of vaccine uptake were reported among older participants and those with a higher level of education. However, nurses, HCWs with a previous HPV infection, those with a family history of cervical cancer, or those with a previous cervical cancer screening test had higher odds of receiving the vaccine. On the other hand, older participants and diploma degree holders were less willing to take the HPV vaccine. Higher odds of willingness were reported in married HCWs, those with a previous HPV infection, those who received a previous HPV vaccine dose, or those who were screened for cervical cancer. Lack of knowledge and some misconceptions were the most reported reasons for hesitancy. Conclusion: Certain factors that affect HCWs personal decisions to take the vaccine were identified. By targeting these issues, epidemiologists, public health officials and women's health care providers can work to increase HPV vaccine uptake and reduce the burden of HPV-related diseases in this population. Keywords: HPV vaccine, epidemiology, public health, women's health, healthcare worker, uptake There are more than 200 identified types of human papillomavirus (HPV). Clinical manifestations of infection could range from completely asymptomatic to warts or cancer. There are approximately 40 types that are sexually transmitted and infect mucosal surfaces through oral, anal, or vaginal intercourse. These types are divided into high-risk and low-risk types according to their associated cancer risk. Low-risk types of HPV can cause warts. On the other hand, high-risk types of HPV can cause cervical intraepithelial neoplasia and squamous cell carcinomas or adenocarcinomas of the oropharyngeal mucosa and anogenital tract. During the perinatal period, horizontal or vertical transmission of the virus can happen, which could lead to respiratory papillomatosis or oral infections. 1,2 Epidemiological data worldwide have shown that HPV infection is the most frequent sexually transmitted infection, with an estimated lifetime prevalence of 85 to 91% in sexually active females and males, respectively. 2 In Saudi Arabia, cervical cancer is considered the 8th most common cancer among females. Large data sets on the HPV burden in the country are not yet available. Nevertheless, the available recent data on the general population from Western Asia, the region where Saudi Arabia is located, estimated that around 2.5% of females are infected with HPV types 16 or 18 at a given time. Additionally, three quarters (72.4%) of invasive cervical cancer cases are caused by HPV types 16 and 18. 3 Epidemiological studies have identified certain risk factors for HPV infections, such as having multiple sexual partners, starting first sexual intercourse at a young age, being infected with other sexually transmitted organisms or HIV infection, having immunocompromised conditions, or practicing unsafe sexual contact (for example: not using barrier methods). 2</s -Abstract Truncated-
obstetrics & gynecology